An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A company called American Peptides is running a sale with the promo code LOOT10 that gives shoppers up to 30% off a handful of research peptides. The announcement lists specific names like Semax, Selank, Adamax, Dihexa, PE-22-28 and P-21. It’s basically a retail promotion, not a new scientific finding. These names are peptides, which are short chains of amino acids — think of them as tiny proteins. They’re not household drugs like aspirin; many are used in research settings or sold by specialty suppliers. For example, Semax and Selank are peptides that came out of Russian research and have been explored for effects on brain function and mood. Dihexa and others on the list have shown interesting results in early lab work, but that doesn’t mean they’re proven medicines you should use without expert oversight. The announcement is a sales notice, not a research paper. It doesn’t present new data about safety or effectiveness in humans. Most of these peptides have limited clinical testing. Some have been studied in animal experiments or small, early-stage human trials. The promo note’s claim “up to 30% off” is about price, not efficacy, so the real takeaway is cheaper access for buyers, not a change in what science says about how well these substances work. Why this matters depends on who you are. Researchers or labs that legally purchase peptides for experiments might welcome lower prices. Individual consumers who’ve heard buzz about cognitive or mood benefits might see this as an opportunity, but that’s where caution is important. Lower cost can increase temptation to self-experiment with substances that aren’t approved treatments and whose long-term effects aren’t well-known. There are several caveats and risks. Many of these peptides are not approved drugs and are typically sold for “research use only,” meaning they’re not cleared for treating people. Quality control can vary between suppliers. Side effects, safe dosages, and interactions with other medications are often not well established. Pregnant or nursing people, children, and people with chronic health conditions should especially avoid self-administering these compounds. Also, laws vary by country and state about buying and using research peptides, so legal risks exist. Bottom line: It’s a sale on research peptides, not a scientific breakthrough — cheaper purchases, but proceed with caution and don’t assume safety or proven benefit.
Source: Steady